Neck Pain
Background
Neck pain is a widespread condition characterized by discomfort in the cervical spine region, which can often radiate to the shoulders or head. It can present as acute, short-term pain or chronic, long-lasting discomfort. Chronic pain, in particular, tends to have a more significant heritable component compared to acute pain. [1] The experience of pain across various body sites, including the neck, is influenced by an underlying genetic factor. [2]
Biological Basis
Genetic factors play a considerable role in an individual's susceptibility to and experience of neck pain. Research on twins has demonstrated a high heritability for concurrent low back and neck-shoulder pain, indicating a substantial genetic influence on these conditions. [3] The heritability for various painful conditions, such as back pain, is estimated to range from 21% to 58% [4] with back pain specifically showing a heritability of 40%. [1] Genetic factors are also linked to the association between pain catastrophizing and chronic widespread pain. [5]
Genome-wide association studies (GWAS) have been instrumental in identifying genetic markers and understanding the biological mechanisms underlying pain. For instance, genetic factors associated with back pain have been found to influence neurological pathways, including those involved in nervous system development, skeletal muscle development, neurotransmitter transport, and central nervous system projection neuron axonogenesis. [6] Significant enrichment of gene expression in the brain has been observed in relation to these genetic factors. [6]
In the context of neuropathic pain (NP), which can manifest in the head and neck region, specific single nucleotide polymorphisms (SNPs) have been identified through GWAS. Examples include rs10950641 (near SNX8 on chromosome 7q22.3), rs4804217 (near PCP2 on 19p13.2), rs6796803 (near KNG1 on 3q27.3), and rs4775319 (near RORA on 15q22.2) in patients with head and neck cancer. [7] Other candidate genes for NP include COMT, TRPV1, P2X receptor genes, and CACNG2. [4] Variants near the FOXL1 gene, such as rs12596162, have been associated with NP, suggesting the involvement of pathways like the Wnt/β-catenin pathway. [4] Additionally, common variants within the RP11-634B7.4 gene have been linked to severe pre-treatment pain in head and neck cancer patients. [7]
Clinical Relevance
The genetic understanding of neck pain holds significant clinical relevance, as it can guide the development of personalized pain management strategies and identify potential new therapeutic targets. Pain in the head and neck area, particularly in conditions like head and neck cancer, is a critical clinical concern, often resulting from tumor invasion or compression of anatomical structures. [7] Acute pain is frequently reported during and after treatments such as surgery, chemotherapy, and radiotherapy for these conditions. [7]
Genetic insights can also influence how individuals respond to pain treatments. For example, a genetic polymorphism in gamma-aminobutyric acid transaminase is a candidate locus for determining responsiveness to opioid analgesics in patients experiencing cancer pain. [8] Current management approaches for neuropathic pain, which can present as neck pain, include lidocaine patches, high-concentration capsaicin patches, and tramadol. Opiates and botulinum toxin A are generally reserved for refractory cases, often providing only marginal therapeutic benefit. [7] Continued genetic studies are essential to enhance the understanding of the biological mechanisms underlying pain, which can lead to advancements in treatment and management. [7]
Social Importance
Neck pain represents a substantial burden on individuals and society, impacting quality of life, productivity, and healthcare systems. Its widespread prevalence necessitates extensive research efforts, with large-scale genetic association studies involving hundreds of thousands of individuals underscoring the significant societal impact of pain conditions. [6] By identifying genetic markers and understanding the underlying biological mechanisms, researchers aim to develop more effective prevention strategies, facilitate earlier diagnosis, and enable targeted interventions, ultimately improving public health outcomes related to chronic neck pain.
Methodological and Statistical Constraints
Genetic studies of pain, including those relevant to neck pain, face limitations related to the completeness of genomic coverage and the statistical power of their designs. Current genotyping platforms represent only a portion of all known common genetic variations, which can increase the risk of false discoveries by missing true associations. [9] This incomplete genomic representation means that potentially significant genetic contributors to neck pain may remain undiscovered, thus limiting a comprehensive understanding of its genetic architecture. [9] Furthermore, many analyses filter out rare variants and those with uncertain imputation quality, which, while improving data quality, might exclude alleles that could play a crucial role in pain susceptibility or progression . [10], [11]
The statistical power and replicability of findings are also critical considerations. While some studies achieve genome-wide significance, even robust results may originate from relatively small sample sizes for a genome-wide association study (GWAS), necessitating further validation through larger, independent replication cohorts. [9] Observations of nominally significant P-values or inconsistent effects across different replication cohorts, or even complete failure of replication for certain variants, highlight the need for more extensive studies to confirm initial associations and prevent the overestimation of effect sizes . [4], [12] Additionally, analyses focusing on specific pathways may not yield significant findings after stringent adjustments, suggesting that the genetic architecture of pain might involve complex interactions or subtle effects that require refined analytical approaches. [4]
Phenotypic Heterogeneity and Measurement Challenges
The accurate definition and consistent measurement of pain, including neck pain, present inherent challenges due to its subjective nature and varied manifestations. Studies often rely on self-reported questionnaires, such as the painDETECT, which classify individuals based on descriptive qualities of their pain, like burning, tingling, or sensitivity. [4] While these tools aim to differentiate pain types, their subjective nature can introduce variability and potential misclassification, thereby affecting the precision of phenotyping in genetic studies and potentially diluting true genetic signals. [4]
Moreover, the heterogeneity of pain conditions complicates genetic investigations. Research frequently groups various pain types, such as chronic widespread pain or back pain, which may have overlapping but distinct genetic underpinnings from localized neck pain . [3], [6], [13] This broad phenotyping could reduce the statistical power for detecting specific genetic variants associated solely with neck pain. [14] Furthermore, methodological decisions, such as not adjusting for covariates like height and body mass index because they might be part of a causal pathway, could, in some contexts, introduce unaddressed confounding or mask direct genetic effects if these factors also act as independent modifiers. [15]
Generalizability and Unexplained Genetic Factors
A significant limitation in the genetics of pain, including studies relevant to neck pain, is the restricted generalizability of findings across diverse populations. Many large-scale genetic association studies have been predominantly conducted in cohorts of European ancestry . [6], [9], [15] This demographic bias is critical because pain responses, the efficacy of analgesics, and underlying genetic variations are known to differ significantly among various ethnic populations. [9] Consequently, findings from one ancestral group may not be directly transferable or applicable to others, as evidenced by instances where genetic variant effect directions were contrary between discovery and replication samples from different ethnic backgrounds. [12]
Despite identifying specific genetic loci associated with pain-related traits, a substantial portion of the heritability for complex pain conditions, such as back pain, often remains unexplained. [6] This phenomenon, known as "missing heritability," suggests that numerous genetic factors, potentially including rare variants, structural variations, or complex gene-environment interactions, have yet to be discovered or fully characterized . [6], [9] Since genetic association studies primarily identify statistical relationships, there is an ongoing need for extensive mechanistic research in both human and animal models to elucidate the biological pathways and functional consequences underlying these genetic associations, thereby translating statistical findings into actionable clinical insights . [4], [9]
Variants
Genetic variations play a crucial role in an individual's susceptibility to neck pain, influencing biological pathways involved in neural development, pain processing, and tissue integrity. Several single nucleotide polymorphisms (SNPs) have been identified through genome-wide association studies (GWAS) that are associated with neck or shoulder pain, highlighting a complex genetic architecture underlying this common condition. [16] These variants often affect genes involved in fundamental cellular processes, nervous system function, and structural components, contributing to varied pain experiences.
Among the identified variants, rs2401137 in the RERE gene and multiple variants in the FOXP2 gene, including rs1476535, rs34291892, and rs2049604, are notable. The RERE gene encodes a protein involved in transcriptional regulation and chromatin remodeling, processes critical for cellular differentiation and development. Variants like rs2401137 may alter RERE's function, potentially impacting neural development or the body's response to injury and inflammation, which could contribute to chronic pain states. [16] Meanwhile, FOXP2 is a transcription factor well-known for its essential role in brain development, particularly in areas related to speech and language, but also in broader neural circuit formation. Variations in FOXP2 could subtly influence neuronal connectivity, synaptic plasticity, or pain perception pathways, as genetic factors underlying back pain are also implicated in neurological pathways. [6]
Other significant variants include rs12453010 near the CA10 gene and LINC01982, and rs11663694 in the DCC gene. CA10 (Carbonic Anhydrase 10) is a brain-expressed protein implicated in various neurological functions, though its exact enzymatic role remains under investigation. The nearby LINC01982 is a long intergenic non-coding RNA, often acting as a regulatory element for gene expression. Alterations in these regions, such as rs12453010, could disrupt normal brain function or gene regulation, contributing to pain sensitivity. [16] The DCC gene (Deleted in Colorectal Carcinoma) is a critical netrin receptor involved in axonal guidance and neuronal migration during nervous system development. The rs11663694 variant in DCC may affect neural circuit formation, potentially impacting how pain signals are transmitted and processed in the spinal cord and brain, given the importance of nervous system integrity in pain conditions. [4]
Further genetic contributions to neck pain include rs62053992 in LINC01572, rs13107325 in SLC39A8, and rs74425008 located between NDUFB9P2 and CAPZA1P4. LINC01572 is another long intergenic non-coding RNA, whose variants like rs62053992 could influence gene expression patterns relevant to inflammation, tissue repair, or neurological signaling pathways associated with chronic pain. [16] The SLC39A8 gene encodes a zinc transporter essential for zinc homeostasis, a vital process for immune function, neurotransmission, and cellular health. The rs13107325 variant might affect zinc transport, thereby impacting neuronal excitability or inflammatory responses that contribute to neck pain. [4] Lastly, rs74425008 is found in a region containing pseudogenes NDUFB9P2 and CAPZA1P4. While pseudogenes are typically non-coding, they can sometimes play regulatory roles or be in linkage disequilibrium with functional genes, meaning this variant could mark an underlying functional alteration that influences susceptibility to neck pain. [16]
Key Variants
| RS ID | Gene | Related Traits |
|---|---|---|
| rs2401137 | RERE | tonsillectomy risk measurement neck pain |
| rs1476535 rs34291892 |
FOXP2 | attention deficit hyperactivity disorder, Cannabis use social inhibition quality, attention deficit hyperactivity disorder, substance abuse trauma exposure measurement body height post-traumatic stress disorder |
| rs12453010 | CA10 - LINC01982 | gastroesophageal reflux disease educational attainment neck pain |
| rs11663694 | DCC | smoking cessation neck pain |
| rs2049604 | FOXP2 | neck pain health study participation self reported educational attainment aggressive behavior quality, ADHD symptom measurement post-traumatic stress disorder |
| rs62053992 | LINC01572 | neck pain intelligence body height sexual dimorphism measurement |
| rs13107325 | SLC39A8 | body mass index diastolic blood pressure systolic blood pressure high density lipoprotein cholesterol measurement mean arterial pressure |
| rs74425008 | NDUFB9P2 - CAPZA1P4 | neck pain |
Defining Neck Pain and its Related Terminology
Neck pain, as a common musculoskeletal complaint, is primarily characterized by self-reported discomfort or pain localized to the cervical region. While a universally accepted "gold-standard" definition for specific pain conditions, including neck pain, is often not available, as noted in research on related conditions like back pain . [6], [15] Terminology for pain conditions frequently includes anatomical descriptors, such as "neck-shoulder pain," to encompass pain that extends beyond the immediate cervical area into adjacent regions. [3] The conceptual framework for defining such conditions generally relies on an individual's subjective reporting of pain presence, its location, and its qualitative characteristics.
Classification and Duration-Based Criteria
Classification systems for pain conditions commonly distinguish between acute and chronic presentations using duration-based criteria, a principle applicable to neck pain. For example, studies on back pain have defined chronic cases with durations exceeding three months, six months, or even a cumulative twelve months of pain achieved through one month of pain in consecutive years . [6], [15] This categorization by chronicity is a fundamental nosological system in pain research, influencing both clinical and research definitions. Furthermore, the practice of differentiating between broader "back pain" and more anatomically specific "low back pain" [15] suggests that similar subtyping based on precise localization could be applied to neck pain, allowing for more granular classification.
Measurement Approaches and Diagnostic Considerations
Operational definitions for pain conditions predominantly utilize patient self-report, often gathered through direct questions about the type and experience of pain within a defined period, such as "Pain type(s) experienced in last month". [6] For research, diagnostic criteria can also incorporate quantitative pain scores, with specific thresholds, like a "pain score ≥4," used to identify cases. [14] Beyond simple presence, comprehensive measurement approaches may involve specialized questionnaires, such as the painDETECT tool, which assesses symptoms like burning, tingling, or sensitivity to help distinguish between neuropathic and nociceptive pain components. [4] A persistent challenge in pain research, relevant to neck pain, is the variability in phenotyping across studies, highlighting the importance of developing standardized vocabularies and consensus guidelines to promote definitional consistency . [6], [17]
Manifestations and Subjective Assessment of Neck Pain
Neck pain presents with a variety of qualities that are crucial for its clinical characterization. Individuals commonly report symptoms such as burning pain, tingling sensations, sudden onset pain, and altered sensitivity to heat and cold. [4] These subjective descriptions provide insight into the potential underlying mechanisms of pain. To systematically capture these experiences, tools like the painDETECT questionnaire are used, which is scored from 0 to 39 on a Likert scale. [4] This questionnaire helps differentiate between neuropathic and nociceptive pain components based on the patient's description of qualities such as burning, tingling, and sensitivity to temperature. [4] The variability in how individuals perceive and articulate these symptoms highlights the importance of detailed subjective assessment in understanding the diverse presentation of neck pain.
Phenotypic Spectrum and Objective Measures
The clinical presentation of neck pain encompasses a broad phenotypic spectrum, ranging from acute episodes to chronic conditions. Chronic pain is typically defined by its duration, often exceeding three months, though definitions can vary, sometimes including pain present for at least one month in consecutive years. [15] Neck pain frequently co-occurs with low back and shoulder pain, suggesting a broader regional involvement, and studies indicate a significant heritable component for such concurrent pain presentations. [3] Beyond subjective reporting, future research aims to incorporate more quantitative and objective pain measurements. These include assessing pain sensitivity and thresholds to temperature or pressure stimuli, as well as utilizing functional magnetic resonance imaging (fMRI) to provide deeper insights into pain processing pathways. [13]
Phenotypic diversity in neck pain is influenced by various factors, including inter-individual differences, age-related changes, and sex, which are often accounted for as covariates in pain analyses. [18] For instance, pain in the head and neck region, particularly in patients with head and neck cancer, can arise from specific etiologies such as tumor invasion or compression of anatomical structures. [18] The heterogeneity in pain definitions across different studies, where chronic pain might be defined by varying durations, can lead to diverse phenotypic classifications and may influence the identification of genetic associations pertinent to specific pain subtypes. [15] This variability underscores the need for precise and consistent phenotyping to advance the understanding of the complex mechanisms contributing to neck pain.
Diagnostic Implications and Prognostic Factors
The symptoms of neck pain carry significant diagnostic implications and can serve as prognostic indicators. Acute pain in the head and neck, especially post-surgical or post-treatment pain in cancer patients, is a critical clinical concern and may signal serious underlying issues like tumor invasion or compression of neural structures. [18] Beyond immediate causes, genetic factors contribute to individual pain susceptibility; for example, genetic influences have been identified in the association between pain catastrophizing and chronic widespread pain. [5] Genome-Wide Association Studies (GWAS) represent a powerful, agnostic approach to identify genetic markers associated with pain susceptibility and to uncover biological mechanisms, which can inform the development of novel therapeutic targets for conditions including neuropathic pain. [18] While specific biomarkers for neck pain are still under investigation, these genetic insights contribute to a more comprehensive understanding of pain pathways and potential treatment responses. [18]
Causes of Neck Pain
Neck pain, a common musculoskeletal complaint, arises from a complex interplay of genetic predispositions, environmental factors, neurobiological mechanisms, and broader health influences. Research indicates that while external factors often trigger symptoms, an individual's inherent genetic makeup significantly modulates susceptibility and pain perception.
Genetic Heritability and Predisposition
Genetic factors play a substantial role in the development and persistence of neck pain, contributing significantly to its heritability. Studies on twins have shown a high heritability for concurrent low back and neck-shoulder pain, suggesting that shared genetic influences underpin pain experiences across different spinal regions. [3] This indicates a polygenic risk, where multiple inherited gene variants collectively increase an individual's susceptibility to developing neck pain. Furthermore, a single underlying genetic factor has been found to explain pain reporting at various body sites, implying a general genetic susceptibility to pain rather than site-specific genetic determinants. [2] This broad genetic architecture suggests that individuals may inherit a generalized predisposition to pain, which can manifest in the neck depending on other contributing factors. The heritability of spinal pain, including neck pain, has been comprehensively analyzed in population-based twin samples, confirming a significant genetic component. [19]
Neurobiological and Structural Genetic Pathways
Specific genetic variations influence neurobiological pathways involved in pain processing and the structural integrity of the cervical spine. Genetic factors underlying back pain, which often co-occurs with neck pain, have been implicated in neurological pathways, with enrichment observed in gene sets related to nervous system development and projection neuron axonogenesis. [6] For instance, the CACNG2 gene has been linked to susceptibility to chronic pain following nerve injury, highlighting its role in modulating pain signals. [4] Other genes, such as TRPV1 (specifically the Ile585Val variant), COMT, and P2X receptor genes, are also recognized for their involvement in neuropathic pain mechanisms. [4] Additionally, genetic determinants of bone mineral density, such as the WLS and CCDC170/ESR1 loci and the EN1 gene, influence skeletal strength and structure . [20], [21] While these are often studied in the context of other bone sites, their relevance to overall skeletal health suggests a potential role in the structural resilience of the cervical spine, which can impact neck pain development.
Environmental and Lifestyle Influences
Beyond genetic predispositions, a range of environmental and lifestyle factors contribute to the onset and exacerbation of neck pain. Socioeconomic factors, such as educational attainment, have been explored in relation to back pain risk, even when accounting for genetic influences. [22] This suggests that environmental circumstances, which can include occupational demands, posture, and access to resources, independently contribute to pain conditions. Lifestyle choices, such as smoking behaviors, are also recognized risk factors for general pain conditions. [6] While not exclusively for neck pain, these factors highlight how daily habits and external exposures can interact with an individual's susceptibility to manifest pain.
Complex Interactions and Comorbidities
Neck pain often arises from complex gene-environment interactions and is frequently associated with other health conditions. Genetic predispositions can interact with environmental triggers, influencing the likelihood and severity of pain; for example, genetic markers for spinal degeneration may interact with markers for pain processing. [15] Early life influences, though not explicitly detailed in the context for neck pain epigenetics, are generally understood to shape an individual's health trajectory, potentially influencing pain susceptibility later in life. Furthermore, neck pain can be comorbid with other health issues, such as sleep disturbances, depression symptoms, and chronic widespread pain, with studies showing both genetic and environmental influences on these interconnected conditions . [13], [23] The presence of these comorbidities can amplify pain experiences and complicate management, indicating a holistic view is necessary for understanding the causes of neck pain.
Genetic Predisposition and Heritability of Neck Pain
Neck pain, similar to back pain, demonstrates a significant genetic component, with heritability estimates for back pain reaching approximately 40%, and potentially higher for chronic forms. [15] Twin studies have further revealed a high heritability for concurrent low back and neck-shoulder pain, indicating shared genetic influences across different body sites. [3] Genome-wide association studies (GWAS) are instrumental in identifying specific genetic locations, or single-nucleotide polymorphisms (SNPs), that are associated with pain phenotypes, providing crucial insights into the underlying biological mechanisms. [4] These genetic factors are not only implicated in the development of chronic pain post-surgery, but also in broader neurological pathways, highlighting a complex interplay of inherited predispositions. [24]
Genetic analyses of back pain have identified an enrichment of gene sets related to nervous system development and skeletal muscle development, suggesting that the architecture of the nervous and musculoskeletal systems plays a key role in pain susceptibility. [6] For instance, specific genetic variants such as those in SOX5 and DCC have been associated with chronic back pain, with DCC (Deleted in Colorectal Carcinoma) also known for its involvement in spinal cord pain processing through Netrin-1 interactions. [15] Other genes, including SNX8, PCP2, KNG1, and RORA, have been identified in association with neuropathic pain, underscoring the diverse genetic landscape contributing to various pain types. [18] The genetic architecture of pain also extends to psychological aspects, as genetic factors have been shown to explain the association between pain catastrophizing and chronic widespread pain. [5]
Molecular Signaling and Neuropathic Mechanisms
At the molecular and cellular level, neck pain and related neuropathic conditions involve intricate signaling pathways that modulate pain transmission and sensitization. Key biomolecules, including Protein Kinase A, Protein Kinase C (PRKCA), and Src family kinases, play a critical role in C-fiber-induced ERK (Extracellular signal-regulated kinase) activation and cAMP (cyclic adenosine monophosphate) response element-binding protein phosphorylation within dorsal horn neurons, processes central to the development of central sensitization. [25] PKCα has also been genetically linked to memory, suggesting broader neurological implications. [26] Furthermore, olfactory receptor genes have been shown to activate MAP kinases (mitogen-activated protein kinases), which are important for olfactory sensory neurons and other cellular processes like wound healing and cell proliferation. [18]
Neuropathic pain, a common component of neck pain, is characterized by distinct molecular and cellular mechanisms, which can vary depending on the specific method of pain induction. [4] Genes such as CACNG2 influence susceptibility to chronic pain following nerve injury, while variants in TRPV1 (Transient Receptor Potential Vanilloid 1) and P2X receptor genes are also implicated in neuropathic pain pathways. [27] Neuroimmune interactions are also crucial, with variants in genes like IL10 (Interleukin 10) highlighting the importance of the immune system in neuropathic pain development. [18] Genetic studies have also shown enrichment in pathways related to the positive regulation of neurotransmitter transport, emphasizing the role of efficient neurotransmission in pain modulation. [6]
Neurodevelopmental and Structural Foundations
The biological basis of neck pain is also rooted in the development and integrity of the nervous and musculoskeletal systems. Genetic studies indicate an enrichment of genes involved in nervous system development and skeletal muscle development in individuals with back pain, which can be extrapolated to neck pain due to anatomical and functional commonalities. [6] Specifically, the process of central nervous system projection neuron axonogenesis is highlighted, suggesting that the formation and connectivity of neural pathways are critical to pain perception and chronicity. [6] While structural changes like intervertebral disc degeneration or herniation are often attributed to back pain, they explain only a small fraction of its genetic influence, indicating that functional predispositions involving higher-order neurological processes are more significant. [15]
The expression of genes associated with back pain is significantly enriched in brain tissue, underscoring the brain's central role in processing and maintaining pain. [6] Beyond neural components, the integrity of structural components is also relevant; for example, carbohydrate sulfotransferase 3 (CHST3) deficiency can lead to congenital joint dislocations, which could predispose individuals to chronic pain conditions. [28] Although specifically related to the lumbar spine, the unique architectural design of muscles like the multifidus highlights the importance of muscular support and stability in preventing spinal pain, a principle applicable to the cervical region as well. [29] This suggests a complex interplay between genetic factors influencing development, structural integrity, and neurological function in the manifestation of neck pain.
Central Sensitization and Systemic Interactions
Chronic neck pain often involves central sensitization, a phenomenon where the central nervous system becomes hyper-responsive to stimuli, leading to heightened pain perception and spread. This process involves structural and functional changes within the brain and spinal cord, which contribute to the development and maintenance of chronic pain states. [30] The immune and nervous systems are deeply interconnected in this process, playing a central role in both the initiation and persistence of chronic pain. [30] For instance, neuroimmune interactions, potentially mediated by genes like IL10, are crucial in the context of neuropathic pain. [18]
Beyond the direct neural and immune pathways, systemic factors and comorbidities significantly influence the experience of chronic pain. Obesity and chronic pain frequently co-occur, and extrinsic factors such as sleep disturbance can exacerbate chronic pain conditions. [30] Altered sleep quality and disrupted circadian rhythms are common in individuals experiencing chronic pain, further illustrating the broad systemic consequences that interact with and contribute to the pain experience. [30] These systemic interactions highlight that neck pain, particularly in its chronic forms, is not merely a localized issue but a complex condition influenced by a wide range of biological processes and their interconnections throughout the body.
Neuronal Signaling and Central Sensitization
Pain perception involves intricate neuronal signaling pathways that can lead to central sensitization, a key mechanism in chronic pain states. Activation of ionotropic and metabotropic receptors, alongside intracellular signaling cascades involving protein kinase A, protein-kinase C (PKC), and Src, contributes to the phosphorylation of ERK and cAMP response element-binding protein in dorsal horn neurons. [25] This cascade of events is fundamental to the development of central sensitization, where the nervous system exhibits increased excitability, leading to heightened pain sensitivity. [25] Genetic variants in the protein-kinase C gene have been highlighted in association with neuropathic pain symptoms, underscoring the role of this pathway in disease susceptibility. [4]
Further molecular interactions within these pathways involve mitogen-activated protein kinases (MAPK/ERK), which are activated by various stimuli, including odorant-activated olfactory receptor genes . [18], [31] These MAP kinases play critical roles in neuronal function and have been identified as important for pain, with MAPK1/ERK2 suggested as novel therapeutic targets in pain patients. [18] Additionally, the PKCα isoform has been genetically linked to memory processes, suggesting broader roles for PKC signaling in neural plasticity and function relevant to persistent pain states. [26] Genetic factors influencing the positive regulation of neurotransmitter transport also contribute to the complexity of these neurological pathways in pain. [6]
Neuro-Immune and Metabolic Crosstalk
The interplay between the immune and nervous systems is a significant pathway in nociception and the development of chronic pain, involving extensive pathway crosstalk and network interactions. [30] Neuroinflammation, a condition where immune cells and their mediators affect nervous system function, is implicated in the pathogenesis of neuropathic pain. [30] Chronic inflammation, often linked with conditions like obesity, can also exacerbate chronic pain by influencing immune responses and metabolic activities. [30]
Metabolic pathways, including energy metabolism and metabolic regulation, also play a critical role in pain modulation. Obesity and chronic pain are frequently comorbid, partly due to the metabolic activity of adipose tissue, which can influence pain perception and inflammation. [30] The CRTC3 gene links catecholamine signaling to energy balance, highlighting a regulatory mechanism where metabolic state can impact pain-related processes. [32] Furthermore, links between the hippocampus and tumor necrosis factor (TNF) suggest a connection between chronic pain, inflammation, and mood disorders, revealing a systems-level integration of these mechanisms. [33]
Central Nervous System Plasticity and Regulation
The central nervous system undergoes significant plasticity and regulatory changes in response to pain, contributing to its chronic nature. Genetic factors underlying pain are closely involved in neurological pathways, impacting nervous system development and central nervous system projection neuron axonogenesis. [6] Studies indicate a significant enrichment of gene expression in the brain for pain-related genetic factors, underscoring the brain's central role in pain processing and its underlying genetic architecture. [6]
Central pain mechanisms involve specific and plastic changes within the brain, leading to altered pain perception and processing . [34], [35] Hierarchical regulation within brain networks, such as corticostriatal functional connectivity, has been shown to predict the transition from acute to chronic back pain, demonstrating an emergent property of neural networks in persistent pain states. [36] Additionally, sleep changes and disruptions in circadian rhythm are commonly observed in individuals with chronic pain, suggesting a regulatory link between these biological cycles and pain perception. [30]
Genetic Architecture and Pathway Dysregulation
Genetic predisposition significantly influences an individual's susceptibility to chronic pain, with genome-wide association studies (GWAS) identifying specific gene variants and pathway dysregulation. [37] For instance, in patients with head and neck cancer neuropathy, novel target genes identified include SNX8, PCP2, KNG1, and RORA. [18] These genetic findings suggest specific pathways whose dysregulation contributes to the development of neuropathic pain and may offer targets for therapeutic intervention. [18] The protein-kinase C gene has also been highlighted for its variant associations with neuropathic pain symptoms. [4]
Beyond individual genes, broader genetic influences on chronic widespread pain have been established, emphasizing the role of gene regulation and protein modification in pain mechanisms. [37] These genetic insights provide a crucial step towards understanding the molecular underpinnings of chronic post-surgical pain and developing personalized pain medicine. [24] Investigating the physiological effects of identified single nucleotide polymorphisms (SNPs) and their impact on gene expression levels (eQTLs) can further elucidate the biological mechanisms and potential therapeutic targets for pain management. [13]
Genetic Architecture and Risk Stratification
The genetic architecture of pain, including neck pain, is complex and highly polygenic, with studies indicating a significant heritable component for concurrent low back and neck-shoulder pain. [3] This genetic predisposition suggests that individual variations can influence susceptibility to developing neck pain and its chronicity. Understanding this architecture is crucial for identifying individuals at higher risk, enabling targeted prevention strategies or earlier interventions before the condition becomes entrenched. Such insights contribute to a personalized medicine approach, where treatment and management plans are tailored to an individual’s genetic, environmental, and lifestyle characteristics, moving beyond a one-size-fits-all model. [38]
Genetic studies, particularly genome-wide association studies (GWAS), aim to uncover underlying mechanisms of disease conditions and identify novel targets for drug development. [18] For instance, specific single nucleotide polymorphisms (SNPs) in genomic regions like 7q22.3 (rs10950641; SNX8), 19p13.2 (rs4804217; PCP2), 3q27.3 (rs6796803; KNG1), and 15q22.2 (rs4775319; RORA) have been implicated in neuropathy among head and neck cancer patients, a precursor to neuropathic pain. [18] While these findings are specific to cancer-related neuropathy, they exemplify how genetic markers can serve as prognostic indicators for disease progression and guide the selection of more effective monitoring strategies for pain in the head and neck region.
Clinical Assessment and Prognostic Indicators
Clinical assessment of neck pain benefits from tools designed to characterize pain types, such as the painDETECT questionnaire, which helps distinguish neuropathic from nociceptive components, even if primarily validated for back pain. [4] This diagnostic utility is vital for appropriate treatment selection, as neuropathic pain often requires different management strategies. Identifying specific prognostic factors, like the extent of tumor invasion or compression of anatomical structures in head and neck cancer patients, can predict the severity and progression of pain in the neck region. [18]
Beyond diagnosis, understanding these prognostic indicators allows clinicians to anticipate disease progression and long-term implications for patient care. For instance, in head and neck cancer, factors like TNM classification are critical prognostic determinants influencing both treatment pathways and expected pain outcomes. [38] Monitoring strategies can then be tailored to observe these predicted trajectories, adjusting interventions as needed to optimize pain control and improve patient quality of life. The significant inter-individual variability in pain sensitivity and analgesic response further underscores the need for continuous monitoring and adaptive care plans. [38]
Therapeutic Implications and Comorbidities
The management of neck pain is complicated by substantial inter-individual variability in pain sensitivity and analgesic response, necessitating tailored therapeutic strategies. [38] This variability highlights the importance of genetic insights, which can inform treatment selection and predict responsiveness to different interventions. For instance, understanding the genetic underpinnings of neuropathic pain, such as variants in SNX8, PCP2, KNG1, and RORA, could lead to the development of novel therapeutic targets and more effective management strategies for pain in the head and neck region. [18]
Neck pain often presents within a broader context of comorbidities and overlapping pain phenotypes, which significantly impact patient care. Studies indicate a high heritability for concurrent low back and neck-shoulder pain, suggesting shared genetic and biological pathways. [3] Furthermore, patients with head and neck cancer, who frequently experience neck pain due to tumor invasion, often present with other comorbidities such as hypertension, heart disease, lung disease, diabetes, stroke, and liver disease. [38] These associated conditions can complicate pain management, influence treatment choices, and impact overall patient outcomes, emphasizing the need for a comprehensive, multidisciplinary approach that considers the patient's full clinical picture. The interplay of genetic factors, psychological aspects like pain catastrophizing, and various comorbidities further dictates the patient's pain experience and treatment efficacy. [39]
Frequently Asked Questions About Neck Pain
These questions address the most important and specific aspects of neck pain based on current genetic research.
1. Why does my chronic neck pain feel worse than my friend's?
Your personal experience of chronic pain, including neck pain, is significantly influenced by your genetics. Research shows an underlying genetic factor affects how intensely you perceive pain across different body sites. So, even with similar physical conditions, your genetic makeup can make your pain feel more severe.
2. Will my kids definitely get neck pain if I have it?
Not necessarily, but they might have an increased susceptibility. Conditions like low back and neck-shoulder pain show high heritability, meaning genetics play a substantial role. While you pass on genes, it often means a higher risk or predisposition, not a guaranteed outcome, as other factors also contribute.
3. Does stress make my neck pain worse due to my body's wiring?
Yes, genetic factors are linked to how you process pain, including "pain catastrophizing," which is an exaggerated negative mindset towards pain. This genetic predisposition can amplify the impact of stress on your chronic widespread pain, including in your neck, making it feel worse.
4. Why don't common pain medications work well for my neck?
Your genes can influence how your body processes and responds to certain pain treatments. For example, a genetic variation in gamma-aminobutyric acid transaminase can affect how well opioid analgesics work for you. This means that for some people, standard medications might offer only marginal relief due to their unique genetic profile.
5. Could a genetic test help doctors treat my neck pain better?
Potentially, yes. Understanding your genetic profile can guide the development of personalized pain management strategies. By identifying specific genetic markers, doctors could one day select more effective treatments or explore new therapeutic targets tailored to your biological mechanisms of pain.
6. Is my chronic neck pain purely biological, not "in my head"?
Your chronic neck pain has a strong biological basis, significantly influenced by genetic factors. Research indicates that genes affect neurological pathways, including those involved in nervous system development and neurotransmitter transport, with significant gene expression in the brain. This confirms a real, physical component to your pain experience.
7. Why do I get chronic neck pain when my sibling doesn't?
While neck and shoulder pain have high heritability, genetic influence doesn't mean a 100% chance for everyone in a family. Your individual genetic variations, even compared to a sibling, can lead to different susceptibilities and experiences of pain. Environmental factors also play a role in how these genes are expressed.
8. Why do some people tolerate neck pain better than me?
Genetic factors significantly influence an individual's susceptibility to and experience of pain. Some people are genetically wired to have a higher pain threshold or a different way of processing pain signals, making them seem more tolerant. Your genes play a considerable role in how you perceive and cope with discomfort.
9. Is it true that my body is wired to feel more pain?
Yes, it's true that your genetic makeup can influence how your body is wired for pain perception. Genetic factors have been found to affect neurological pathways, including those in the central nervous system, which are crucial for processing pain signals. This can lead to a heightened susceptibility to and experience of pain.
10. Does my family's history of back pain mean my neck hurts more?
There's a strong connection. Research on twins shows high heritability for concurrent low back and neck-shoulder pain, and an underlying genetic factor influences pain across various body sites. So, a family history of back pain could indeed indicate a shared genetic predisposition that contributes to your neck pain experience.
This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.
Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.
References
[1] Suri, P. "Genome-Wide Meta-Analysis of 158,000 Individuals of European Ancestry Identifies Three Loci Associated with Chronic Back Pain." PLoS Genetics, 2019.
[2] Williams, F. M., et al. "Pain reporting at different body sites is explained by a single underlying genetic factor." Rheumatology (Oxford), vol. 49, no. 9, Sept. 2010, pp. 1753–1755. PubMed, PMID: 20627917.
[3] Nyman T et al. High heritability for concurrent low back and neck-shoulder pain: a study of twins. Spine (Phila Pa 1976), 2011, vol. 36, no. 22, pp. E1469–1476.
[4] Warner SC et al. Genome-wide association scan of neuropathic pain symptoms post total joint replacement highlights a variant in the protein-kinase C gene. European Journal of Human Genetics, 2017, vol. 25, no. 3, pp. 360–367.
[5] Ogata, S., et al. "Genetic Factors Explain the Association Between Pain Catastrophizing and Chronic Widespread Pain." J Pain, 2017.
[6] Freidin MB et al. Insight into the genetic architecture of back pain and its risk factors from a study of 509,000 individuals. Pain, 2019, vol. 160, no. 6, pp. 1426–1441.
[7] Reyes-Gibby, C. C. "Genome-wide association study identifies genes associated with neuropathy in patients with head and neck cancer." Sci Rep, vol. 9, no. 1, June 2019, p. 8417. PubMed, PMID: 29884837.
[8] Yokoshima, Y., et al. "Gamma-aminobutyric acid transaminase genetic polymorphism is a candidate locus for responsiveness to opioid analgesics in patients with cancer pain: An exploratory study." Neuropsychopharmacol Rep, vol. 39, no. 1, Mar. 2019, pp. 10–15. PubMed, PMID: 30277654.
[9] Kim, H. "Genome-wide association study of acute post-surgical pain in humans." Pharmacogenomics, 2009.
[10] Pei, Y. F. et al. "Genome-wide association meta-analyses identified 1q43 and 2q32.2 for hip Ward's triangle areal bone mineral density." Bone, 2016.
[11] Liu, L. et al. "Two novel pleiotropic loci associated with osteoporosis and abdominal obesity." Hum Genet, 2020.
[12] Ran, S. et al. "Bivariate genome-wide association analyses identified genes with pleiotropic effects for femoral neck bone geometry and age at menarche." PLoS One, 2013.
[13] Peters, M. J., et al. "Genome-wide association study meta-analysis of chronic widespread pain: evidence for involvement of the 5p15.2 region." Ann Rheum Dis, vol. 72, no. 3, 2013, pp. 427–36.
[14] Lee, E. et al. "Genome-wide enriched pathway analysis of acute post-radiotherapy pain in breast cancer patients: a prospective cohort study." Hum Genomics, 2019.
[15] Suri, P et al. "Genome-wide meta-analysis of 158,000 individuals of European ancestry identifies three loci associated with chronic back pain." PLoS Genetics, vol. 14, no. 9, 2018, e1007601.
[16] Meng W. A genome-wide association study finds genetic variants associated with neck or shoulder pain in UK Biobank. Hum Mol Genet. 2020;29(10):1772-1780.
[17] Deyo, R. A., et al. "Report of the NIH Task Force on Research Standards for Chronic Low Back Pain." The Spine Journal, 2014.
[18] Reyes-Gibby CC et al. Genome-wide association study identifies genes associated with neuropathy in patients with head and neck cancer. Scientific Reports, 2018, vol. 8, no. 1, p. 8824.
[19] Hartvigsen, J et al. "Heritability of spinal pain and consequences of spinal pain: a comprehensive genetic epidemiologic analysis using a population-based sample of 15,328 twins ages 20–71 years." Arthritis and Rheumatism, vol. 61, no. 10, 2009, pp. 1343–1351.
[20] Mullin, BH et al. "Genome-wide association study using family-based cohorts identifies the WLS and CCDC170/ESR1 loci as associated with bone mineral density." BMC Genomics, vol. 17, no. 1, 2016, p. 157.
[21] Zheng, HF et al. "Whole-genome sequencing identifies EN1 as a determinant of bone density and fracture." Nature, vol. 526, no. 7571, 2015, pp. 112–117.
[22] Zadro, JR et al. "Does educational attainment increase the risk of low back pain when genetics are considered? A population-based study of Spanish twins." The Spine Journal, vol. 17, no. 4, 2017, pp. 518–530.
[23] Gasperi, M et al. "Genetic and Environmental Influences on Sleep, Pain, and Depression Symptoms in a Community Sample of Twins." Psychosomatic Medicine, vol. 79, no. 6, 2017, pp. 646–654.
[24] Clarke, H., et al. "Genetics of chronic post-surgical pain: a crucial step toward personal pain medicine." Can J Anesth, 2015.
[25] Kawasaki, Y., et al. "Ionotropic and metabotropic receptors, protein kinase A, protein kinase C, and Src contribute to C-fiber-induced ERK activation and cAMP response element-binding protein phosphorylation in dorsal horn neurons, leading to central sensitization." J Neurosci, vol. 24, no. 37, 2004, pp. 8310–8321.
[26] de Quervain, D. J. F., et al. "PKCα is genetically linked to memory." Nat Neurosci, vol. 1, no. 5, 1998, pp. 394–5.
[27] Nissenbaum, J., et al. "Susceptibility to chronic pain following nerve injury is genetically affected by CACNG2." Genome Res, 2010.
[28] Hermanns, P., et al. "Congenital joint dislocations caused by carbohydrate sulfotransferase 3 deficiency in recessive Larsen syndrome and humero-spinal dysostosis." Am J Hum Genet, 2008.
[29] Ward, SR., et al. "Architectural analysis and intraoperative measurements demonstrate the unique design of the multifidus muscle for lumbar spine stability." J Bone Joint Surg Am, 2009.
[30] Johnston, K. J. A., et al. "Genome-wide association study of multisite chronic pain in UK Biobank." PLoS Genet, vol. 15, no. 6, 2019, e1008164.
[31] Benbernou, N., et al. "Activation of SRE and AP1 by olfactory receptors via the MAPK and rho dependent pathways." Cell Signal, vol. 25, no. 6, 2013, pp. 1486–97.
[32] Song, Y., et al. "CRTC3 links catecholamine signalling to energy balance." Nature, 2010.
[33] Fasick, V., et al. "The hippocampus and TNF: Common links between chronic pain and depression." Neuroscience and Biobehavioral Reviews, vol. 59, 2015, pp. 129–141.
[34] Phillips, K., and D. J. Clauw. "Central pain mechanisms in chronic pain states—Maybe it is all in their head." Best Pract Res Clin Rheumatol, vol. 25, no. 2, 2011, pp. 141–54.
[35] Apkarian, A. V., et al. "Pain and the brain: Specificity and plasticity of the brain in clinical chronic pain." Pain, vol. 152, no. 3, 2011, pp. S49–64.
[36] Baliki, M. N., et al. "Corticostriatal functional connectivity predicts transition to chronic back pain." Nat Neurosci, vol. 15, no. 8, 2012, pp. 1117–9.
[37] Kato, K., et al. "Importance of genetic influences on chronic widespread pain." Arthritis Rheum, vol. 54, no. 5, 2006, pp. 1682–6.
[38] Reyes-Gibby CC et al. Genome-wide association study suggests common variants within RP11-634B7.4 gene influencing severe pre-treatment pain in head and neck cancer patients. Scientific Reports, 2016, vol. 6, p. 34047.
[39] George SZ et al. Evidence for a biopsychosocial model: pain catastrophizing and catechol-O-methyltransferase diplotype predict clinical pain ratings. Pain, 2008, vol. 136, pp. 53–61.